Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA: 600329)
China flag China · Delayed Price · Currency is CNY
27.97
-0.25 (-0.89%)
Sep 6, 2024, 3:00 PM CST

Tianjin Pharmaceutical Da Ren Tang Group Corporation Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
921.94986.71861.79769.14661.7625.57
Upgrade
Depreciation & Amortization
125.08127.78116.56115.53110.8598.15
Upgrade
Other Amortization
6.15.374.112.262.713.09
Upgrade
Loss (Gain) From Sale of Assets
0.05-0.15-1.08-12.32-7.54-29.94
Upgrade
Asset Writedown & Restructuring Costs
44.3644.3620.161.930.920.78
Upgrade
Loss (Gain) From Sale of Investments
-241.89-308.11-274.22-213.49-160.41-182.73
Upgrade
Provision & Write-off of Bad Debts
22.4119.099.224.896.35-0.35
Upgrade
Other Operating Activities
46.7138.9254.0232.6817.8143.33
Upgrade
Change in Accounts Receivable
-152.5374.01-732.29-42.07-113.81-102.7
Upgrade
Change in Inventory
90.06-165.3458.87-47.4110.96-292.56
Upgrade
Change in Accounts Payable
358.85-56.06609.67220.213.81380.44
Upgrade
Change in Other Net Operating Assets
-18.98-18.986.8210.159.75-
Upgrade
Operating Cash Flow
1,121688.49677.25852.4671.42495.49
Upgrade
Operating Cash Flow Growth
57.79%1.66%-20.55%26.95%35.51%41.51%
Upgrade
Capital Expenditures
-113.14-140.93-107.9-156.95-189.16-205.61
Upgrade
Sale of Property, Plant & Equipment
0.080.191.4928.716.7738.35
Upgrade
Cash Acquisitions
---47.61---
Upgrade
Investment in Securities
-146-606.35-65.08-334.9241.05-98.05
Upgrade
Other Investing Activities
242.41178.18206.82151.3215.12164.53
Upgrade
Investing Cash Flow
-16.65-568.91-12.28-311.8573.77-100.79
Upgrade
Long-Term Debt Issued
-870.86205.65--130
Upgrade
Total Debt Issued
1,117870.86205.65--130
Upgrade
Long-Term Debt Repaid
--807.34-39.87-1.42-1.1-353.14
Upgrade
Total Debt Repaid
-861.09-807.34-39.87-1.42-1.1-353.14
Upgrade
Net Debt Issued (Repaid)
256.1663.52165.78-1.42-1.1-223.14
Upgrade
Issuance of Common Stock
----8.3628.3
Upgrade
Repurchase of Common Stock
-3.39-22.67--1.35-0.7-
Upgrade
Common Dividends Paid
-22.28-877.33-387.43-232.06-232.61-173.35
Upgrade
Other Financing Activities
0.072.7-14.96-9.87-11.21-2.16
Upgrade
Financing Cash Flow
230.56-833.77-236.62-244.7-237.26-370.36
Upgrade
Foreign Exchange Rate Adjustments
0.80.050.01---
Upgrade
Net Cash Flow
1,336-714.15428.35295.85507.9324.34
Upgrade
Free Cash Flow
1,008547.56569.34695.45482.26289.87
Upgrade
Free Cash Flow Growth
70.57%-3.83%-18.13%44.21%66.37%66.27%
Upgrade
Free Cash Flow Margin
12.45%6.66%6.90%10.07%7.30%4.14%
Upgrade
Free Cash Flow Per Share
1.300.710.730.900.630.38
Upgrade
Cash Income Tax Paid
730.97765.94526.93496.73522.98598.75
Upgrade
Levered Free Cash Flow
1,857365.73961.19149.46270.91364.73
Upgrade
Unlevered Free Cash Flow
1,880388.14967.61151.29270.92367.78
Upgrade
Change in Net Working Capital
-1,335122.61-535.27176.45-2.12-142.04
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.